Ratings changes for FuelCell Energy, Peapack-Gladstone Financial, FuelCell Energy, Trip.com Group, Robinhood Markets, Trip.com Group, Qualcomm and more...Upgrade to MarketBeat All Access to get our best stock ideas, proprietary research, portfolio monitoring tools, and more. Start Your Free Trial.

June 26th, 2026

ALERT: Drop these 5 stocks before the market opens tomorrow! (Ad)

The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings research points to the first half of 2026 as a particularly rough stretch for certain holdings.
Some of America's most popular stocks could take serious damage as a radical market shift plays out. Analysts at Weiss Ratings have identified five names you may want to remove from your portfolio before this unfolds.
If any of these are in your portfolio, now is the time to review your positions.

See the 5 stocks to avoid

Today's Top Stories

Rocket Lab's NASA Win Tests Key Support After Sharp Pullback

By Ryan Hasson | June 26, 2026 11:20 AM

A 17-year investing experiment investigated in Dublin (Ad)

By Porter & Company

Palantir’s Valuation Problem Just Met 2 New Growth Catalysts

By Chris Markoch | June 26, 2026 10:10 AM

Data Center Delays Create Opportunity in These 3 Stocks

By Chris Markoch | June 26, 2026 09:00 AM

Goldman Sachs: 300 million jobs will disappear (Ad)

By InvestorPlace

Uncle Sam Plugs In: Nuclear Energy’s Cash Flow Moment Is Finally Here

By Jeffrey Neal Johnson | June 26, 2026 08:25 AM

Qualcomm’s $4B AI Deal Takes Aim at NVIDIA’s Software Moat

By Jeffrey Neal Johnson | June 25, 2026 09:00 AM

Quick Links

Analyst Ratings My MarketBeat Account Settings MarketBeat All Access Stock Lists Stock Screener Calculators Premium Reports Best Stocks to Buy in June

Iran just proved America's energy strategy is broken (Ad)

When the U.S.-Iran deal allowed Iranian oil back into the market, prices fell immediately and energy stocks dropped 1.7%. That's not stability - that's a supply hostage situation repeating since 1973.
Beneath American soil sits an energy source 50,000 times larger than all global oil and gas reserves combined. It can't be sanctioned or embargoed. Last year, a drilling crew hit targets twelve years ahead of schedule. Google signed a 15-year deal. One company sits at the center, and July 4th could be a turning point.

See the company positioned to make OPEC irrelevant

Analysts' Upgrades

FuelCell Energy (NASDAQ:FCEL) was upgraded by Jefferies Financial Group Inc. from "hold" to "buy". They now have a $24.00 price target on the stock, up from $16.00.

H. B. Fuller (NYSE:FUL) was upgraded by JPMorgan Chase & Co. from "neutral" to "overweight". They now have a $67.00 price target on the stock, up from $58.00. This represents a 6.0% upside from the current price of $63.20.

Qualcomm (NASDAQ:QCOM) was upgraded by DZ Bank AG from "hold" to "buy". They now have a $265.00 price target on the stock. This represents a 39.9% upside from the current price of $189.39.

Replimune Group (NASDAQ:REPL) was upgraded by JPMorgan Chase & Co. from "neutral" to "overweight". They now have a $17.00 price target on the stock. This represents a 46.2% upside from the current price of $11.63.

SoftBank Group (OTCMKTS:SFTBY) was upgraded by Deutsche Bank Aktiengesellschaft from "hold" to "buy". The current price is $19.71.

View More Upgrades

The Fourth Reset Has Begun (Ad)

The petrodollar arrangement that anchored the U.S. dollar since 1974 quietly expired in June 2024. Porter Stansberry argues this marks the fourth time in American history that the coin of the realm has been supplanted.
A new monetary architecture, backed by more than sixty nations and initiated through executive orders, is already taking shape. Stansberry's new documentary lays out exactly what is being built and names one specific asset positioned for direct exposure.

Watch the documentary and get the name and ticker now

Analysts' Downgrades

Synaptics (NASDAQ:SYNA) was downgraded by Needham & Company LLC from "buy" to "hold". The current price is $121.00.

View More Downgrades

Dalio’s “Heart Attack” Warning: Take Cover in Gold (Ad)

Bridgewater founder Ray Dalio is warning of an 'economic heart attack' driven by exploding U.S. debt - and he believes stocks, bonds, and the dollar have not priced in the fallout.
Dalio recommends allocating 15% of your portfolio to gold and crypto as protection. One $15 gold fund is already delivering up to $1,152 per month in steady income for investors who act before the next debt shock.

See how to collect your first payout from this gold fund today

Analysts' New Coverage

Achieve Life Sciences (NASDAQ:ACHV) is now covered by Raymond James Financial, Inc.. They set a "strong-buy" rating and a $20.00 price target on the stock. This represents a 232.2% upside from the current price of $6.02.

Agilent Technologies (NYSE:A) is now covered by Sanford C. Bernstein. They set an "outperform" rating and a $155.00 price target on the stock. This represents a 13.7% upside from the current price of $136.29.

Essex Property Trust (NYSE:ESS) is now covered by Sanford C. Bernstein. They set an "outperform" rating and a $320.00 price target on the stock. This represents a 8.3% upside from the current price of $295.38.

Granite Construction (NYSE:GVA) is now covered by Stephens. They set an "overweight" rating and a $180.00 price target on the stock. This represents a 12.2% upside from the current price of $160.44.

Guardant Health (NASDAQ:GH) is now covered by Sanford C. Bernstein. They set an "outperform" rating and a $175.00 price target on the stock. This represents a 17.3% upside from the current price of $149.22.

Natera (NASDAQ:NTRA) is now covered by Sanford C. Bernstein. They set an "outperform" rating and a $310.00 price target on the stock. This represents a 18.4% upside from the current price of $261.91.

NeoVolta (NASDAQ:NEOV) is now covered by Lake Street Capital. They set a "buy" rating and a $11.00 price target on the stock. This represents a 431.4% upside from the current price of $2.07.

Nutex Health (NASDAQ:NUTX) is now covered by B. Riley Financial, Inc.. They set a "buy" rating and a $290.00 price target on the stock. This represents a 74.3% upside from the current price of $166.40.

Provident Financial (NASDAQ:PROV) is now covered by Piper Sandler. They set a "neutral" rating and a $17.00 price target on the stock. This represents a 1.2% downside from the current price of $17.20.

Robinhood Markets (NASDAQ:HOOD) is now covered by BTIG Research. They set a "buy" rating and a $125.00 price target on the stock. This represents a 26.7% upside from the current price of $98.69.

Sensei Biotherapeutics (NASDAQ:FTH) is now covered by Robert W. Baird. They set an "outperform" rating and a $57.00 price target on the stock. This represents a 149.2% upside from the current price of $22.87.

SpaceX (NASDAQ:SPCX) is now covered by Argus. They set a "hold" rating on the stock. The current price is $153.23.

TG-17 (NASDAQ:OBAI) is now covered by Maxim Group. They set a "buy" rating and a $2.00 price target on the stock. This represents a 217.2% upside from the current price of $0.63.

Waters (NYSE:WAT) is now covered by Sanford C. Bernstein. They set an "outperform" rating and a $435.00 price target on the stock. This represents a 16.0% upside from the current price of $374.97.

View More New Coverage

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial